[ad_1]
“We are trying to find new cooperation partners to work for
produce us “, says the head of Biontech, Ugur Sahin
Biontech chief Ugur Sahin assumes that the company will have clarity on additional production quantities for the corona vaccine by the end of January. “We try to win new cooperation partners to produce for us. But it is not as if specialized factories around the world are idle and can produce vaccines of the required quality overnight,” Sahin (55) told the magazine. news “Der Spiegel”.
“At the end of January we will have clarity on whether and how much we can produce more.” At the moment, the generally available vaccines against Covid-19 do not look “optimistic”, “because there are no other approved vaccines and we have to fill this gap with our vaccine,” Sahin said. That is why they are working with US partner Pfizer to explore the possibility of increasing the production of their own preparation.
The Biontech and Pfizer vaccine was approved in the EU just before Christmas and has also been administered for a few days. There are currently no further approvals for corona vaccines in the EU. The international community has already ordered doses of vaccines from several manufacturers that are still in development. “Many other companies were supposed to come with vaccines. Apparently, the impression prevailed: we will get enough, not everything will be so bad and we have it under control. I was surprised,” Sahin said.
On the question of whether Biontech could license other manufacturers to produce the new vaccine, Sahin emphasized the complexity of producing mRNA vaccines. “You can’t just switch so that the vaccine is produced suddenly instead of aspirin or cough syrup. The process requires years of experience and the appropriate structural and technological equipment.”
(WHAT / dpa)
